Search Press releases Keywords From To 27 Jul 2005 UCB first half-year 2005 results including unaudited Half-Year Financial Report Read More 27 Jul 2005 UCB first half-year 2005 results Read More 26 Jul 2005 CIMZIA(TM) demonstrates significant positive results in its two pivotal phase III Crohn's disease trials Read More 25 Jul 2005 UCB Receives Positive Opinion from European Authorities for Orphan Designation of Brivaracetam for the Treatment of Progressive Myoclonic Epilepsies Read More 20 Jul 2005 UCB Confirms Solid First Half Zyrtec Sales in USA Read More 6 Jul 2005 UCB sells its food diagnostics business to Neogen Read More Pagination First page Previous page Previous … Page 188 Page 189 Page 190 Page 191 Current page 192 Page 193 Page 194 Page 195 Page 196 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
